Carebot has secured an investment of more than €1.5 million, the largest in the company’s history. The round was led by Garage Angels and Electron Capital Partners, with JIC Ventures joining the company alongside existing investors Gain Ventures and Eva Janečková.
The investment comes at a time of strong commercial growth. Over the past year, Carebot increased its contracted monthly recurring revenue by 750%, and based on already signed agreements, this figure is expected to grow more than tenfold by the end of the year.
From Certified Products to Real-World Deployment
A key factor behind the investors’ decision was Carebot’s ability to bring certified AI solutions into everyday clinical practice. The company’s technology is now used in hundreds of hospitals across Europe, Vietnam, and the Middle East.
“Carebot has demonstrated that it can successfully implement AI in everyday clinical practice, giving the company a strong opportunity to succeed on a global scale,” says David Zabadal, Investments & Operations at Garage Angels.
Moving from product development and certification to systematic hospital deployment remains one of the most challenging steps in medical AI.
“Carebot is among a small group of European medtech companies that have successfully overcome one of the most difficult barriers in AI diagnostics: moving from a certified product to real-world deployment in hundreds of hospitals, with measurable clinical and commercial impact,” says Marek Nechvátal, Managing Partner at Electron Capital Partners.
Trust From Clinicians as a Foundation for Growth
Direct feedback from radiologists using Carebot in everyday practice also played an important role in JIC Ventures’ decision to invest.
“Radiologists described cases in which Carebot highlighted a finding that might otherwise have been missed. The Carebot team has also shown that it can integrate its technology effectively into the daily operations of hospitals,” says Radim Kocourek of JIC Ventures.
According to the investors, this combination of clinical impact, physician trust, and a growing number of hospital deployments provides a strong foundation for Carebot’s continued expansion across European and global markets.
